Skip to main content

International scientific guideline: ICH topic S1C (R2) - Note for guidance on dose selection for carcinogenicity studies of pharmaceutical

EMEA/CHMP/ICH/383/1995 adopted by the Therapeutic Goods Administration (TGA)

Help us improve the Therapeutic Goods Administration site